FDA authorizes Juul's e-cigarettes for sale in US, source says
UNITED STATES, JUL 17 – The FDA reversed a 2022 ban after Juul showed data that switching completely to its e-cigarettes reduces smokers' exposure to harmful carcinogens, meeting agency health standards.
- The Food and Drug Administration has authorized Juul's e-cigarettes to remain on the market, providing relief to the company after years of struggle.
- The FDA emphasized that the announcement is not an endorsement, warning that non-smokers should not use e-cigarettes.
- Juul's studies claim its e-cigarettes are less harmful for adult smokers who switch from traditional smoking.
- In 2022, Juul settled thousands of lawsuits related to vaping for $1.7 billion.
275 Articles
275 Articles
The manufacturer of electronic cigarettes Juul Labs announced on Thursday that the U.S. Health Authority (FDA) authorized the sale of several of its products in the country, including its vapeer and mentholized capsules. The laboratory was authorized after presenting more than 110 scientific studies to the Food and Drug Administration (FDA), the company said in a statement. The decision means that Juul can continue the sale of products that were…
FDA approves Juul vapes after yearslong delay - West Hawaii Today
The Food and Drug Administration authorized Juul electronic cigarettes for the U.S. market Thursday, ending a lengthy standoff with regulators and lawmakers who accused the company of spurring an epidemic of e-cigarette use among youths.
Coverage Details
Bias Distribution
- 63% of the sources are Center
To view factuality data please Upgrade to Premium